摘要
抑郁症是一种慢性、复发性、致残性精神疾病。近年对抑郁症的发病机制研究已有很大进展。舒肝解郁胶囊是国内首个获批治疗抑郁症的新型抗抑郁纯中药制剂,其作用机制与抑郁症的多种发病机制相关。本文综述其对精神分裂症阴性症状、神经官能症等其他精神疾病以及各类躯体疾病伴发的抑郁症状的疗效和安全性。
Depressive disorder is a chronic, recurrent, disabling mental disease. Great progress has been made in the study on the pathogenesis of depressive disorder. Shugan Jieyu capsule is the first traditional Chinese medicine indicated for depressive disorder. This article reviews Shugan Jieyu capsule's efficacy and safety in the treatment of mental disorder, such as schizophrenia negative symptoms, neurosis and all kinds of physical diseases comorbid depressive symptoms.
出处
《世界临床药物》
CAS
2016年第11期791-792,I0001,I0002,共4页
World Clinical Drug
基金
上海交通大学"医工(理)交叉研究基金"(编号:YG2012MS52)
关键词
舒肝解郁胶囊
精神疾病
躯体疾病
抑郁
疗效
安全性
Shugan Jieyu capsule
mental disease
physical disease
depression
effect
safety